PEDIATRIC UROLOGY

Introduction {#s0005}
============

Urothelial bladder tumour in childhood is extremely rare [@b0005]. Deming (cited in [@b0010]) reported the first such case, in a patient aged \<10 years, in 1924. In 1969, Javadpour and Mostofi [@b0010] identified 40 primary epithelial bladder tumours in the first two decades of life from 10,000 total cases.

A more recent review of previous reports identified 125 patients who were aged \<20 years, of whom only 20 were aged \<10 years [@b0015], and the origin of such cases was mesodermal; reports on this topic are very limited. These tumours have been shown to have a low grade of malignancy, showing little tendency to recur [@b0020], and have a good prognosis. Here we review previous cases and report two new cases of urothelial bladder tumour.

Methods {#s0010}
=======

We reviewed the databases of PubMed and Hinari for reports in English, searched using the keywords 'bladder', 'transitional cell carcinoma' and 'children'. We identified 57 articles [@b0005; @b0010; @b0015; @b0020; @b0025; @b0030; @b0035; @b0040; @b0045; @b0050; @b0055; @b0060; @b0065; @b0070; @b0075; @b0080; @b0085; @b0090; @b0095; @b0100; @b0105; @b0110; @b0115; @b0120; @b0125; @b0130; @b0135; @b0140; @b0145; @b0150; @b0155; @b0160; @b0165; @b0170; @b0175; @b0180; @b0185; @b0190; @b0195; @b0200; @b0205; @b0210; @b0215; @b0220; @b0225; @b0230; @b0235; @b0240; @b0245; @b0250; @b0255; @b0260; @b0265; @b0270; @b0275; @b0280; @b0285], comprising 127 cases ([Table 1](#t0005){ref-type="table"}). We also describe two new cases.

Case 1 {#s0015}
------

A 5-year-old boy from Hadramout, Yemen, presented in 2009 with 1 week of gross haematuria and interrupted urinary stream. There was no significant family, present or previous history. On physical examination at the time of presentation, the patient's vital signs were stable. The abdomen was not tender and not distended. There were no associated anomalies.

There was no recurrence after a 3-year follow-up using abdominal ultrasonography (US) and cystoscopy, with assessments every 3 months in the first year then every 6 months thereafter. [Fig. 1](#f0005){ref-type="fig"}(a--c) shows the histological findings. Sections showed elongated papillary fronds lined by several layers of transitional cells with slightly enlarged crowded nuclei. There was no frank pleomorphism and no stromal invasion. The diagnosis was papillary urothelial neoplasm of low malignant potential (PUNLMP, WHO grade I).

Case 2 {#s0020}
------

A 12-year-old boy from Baghdad, Iraq, presented in August 2013 with two recent attacks of painless haematuria and clots. His medical history indicated a previous appendectomy and tonsillectomy. He also had treatment for rheumatic fever. US and pelvic MRI showed a 2 × 1 cm posterior wall tumour. Cystoscopy was first used 3 months earlier in another hospital and revealed a fungating tumour at the left posterolateral wall near the left ureteric orifice. He underwent transurethral resection of the bladder tumour (TURBT), and the histopathology showed a papillary TCC of low grade and no stromal invasion.

In a reassessment, US showed a soft-tissue lesion in the left bladder wall ([Fig. 2](#f0010){ref-type="fig"}). Cystoscopy ([Fig. 3](#f0015){ref-type="fig"}) showed a villous lesion above the left ureteric orifice of ≈ 2 × 2 cm in diameter. The tumour was resected (TURBT) and the bed cauterised.

The histopathology showed fragments of ulcerated bladder mucosa with intense mixed acute and chronic inflammatory infiltrate ([Fig. 4](#f0020){ref-type="fig"}a--c). There was one small fragment of papillary urothelium with enlarged crowded nuclei, consistent with low-grade papillary urothelial carcinoma (UC). There was no stromal invasion. The child is currently asymptomatic and follow-up cystoscopy is scheduled.

Discussion {#s0025}
==========

True urinary bladder UC in children is very unusual [@b0250], although there are occasional cases. In 1969, Javadpour and Mostofi [@b0010] identified 40 primary epithelial bladder tumours in patients in the first two decades of life, from 10,000 total cases. Most cases [@b0170] were papillary, in patients aged 6--20 years, and who presented with gross haematuria. In the first decade of life, primary bladder carcinoma was suggested to be even more uncommon [@b0050], with 30% of cases in children aged ⩽10 years [@b0245].

Williamson et al. [@b0250] warned that the diagnosis of urothelial tumours in children might be delayed. Urologists might be reluctant to evaluate these patients. The biological behaviour of the tumour must also be considered; the tumour might be of low grade but a follow-up is needed, especially in cases of multiple tumours.

Molecular studies suggest that tumours in children differ in their pathways from those in adult patients. Fine et al. [@b0095] reported a series of 23 urothelial neoplasms in patients aged ⩽20 years. They confirmed that these tumours were of low grade and had a low risk of recurrence.

Alanee and Shukla [@b0245] identified 140 cases of bladder cancer, with PUNLMP and rhabdomyosarcoma comprising 50.7% and 36.4% of the tumours, respectively. Between 1973 and 2003 the incidence of bladder malignancies increased significantly. The conditional survival calculated for 1 and 2 years after diagnosis was 93.6% and 97.5%. Fifty-one cases of embryonal rhabdomyosarcoma were identified. Reviewing the Surveillance, Epidemiology and End Results (SEER) database, they found that bladder cancer in children aged \<18 years was rare, with only 140 patients registered in the SEER database during the period assessed. The results were consistent with previous multi-institutional studies for the higher incidence of PUNLMP in children. They also confirmed a high incidence of these tumours in males (male: female ratio, 3:1).

In the present review we excluded those patients with PUNLMP in the series reported by Alanee and Shukla [@b0245], as there is controversy about the diagnosis of PUNLMP and its accuracy in the SEER registry. The term PUNLMP was only introduced in 2004. In the same study, the survival curves should be considered carefully, as the addition of higher-grade tumours is a limiting factor. Furthermore, based on SEER analysis, there might have been errors in reporting one or more parameters of the malignancies [@b0245].

Data on the molecular characteristics and clinical behaviour of bladder tumours in children are less well understood than those of adult/elderly patients [@b0250; @b0255].

As for the follow-up assessments, CT and virtual cystoscopy are much less invasive [@b0260]. For practical purposes [@b0265; @b0270; @b0275] patients with PUNLMP should be treated similarly to patients with low-grade, noninvasive UC. Molecular grading of these tumours can be used to further assess their biological potential [@b0280].

Because of the low but definite risk of recurrence and grade progression, an appropriate clinical follow-up of patients with primary PUNLMP is warranted [@b0285]. The 1998 WHO/ISUP classification of urothelial neoplasms can be applied reproducibly by pathologists, with a moderate level of agreement. PUNLMP lesions have a more sedate clinical behaviour than UCs but the hazard of recurrence and progression remains, and thus a follow-up is important [@b0285].

In the present report we included articles that were registered after 2004, as was one of the present cases (PUNLMP), but cases of PUNLMP before 2004 were not included.

A univariate analysis [@b0255] showed that high Ki67 expression and low cyclin D1 immunohistological expression were associated with a greater risk of recurrence in the 'young' group, while reduced p27Kip1 expression and p53 overexpression were not. By contrast, reduced p27Kip1 expression correlated with a greater risk of recurrence in elderly patients, suggesting that distinct molecular pathways might be involved in the development and progression of these tumours.

In the hereditary nonpolyposis colorectal cancer syndrome, there is a predisposition to urinary tract involvement [@b0255], but there could be an incidence of urothelial tumours in Costello syndrome [@b0110].

It appears that multiple tumours might be more likely to recur, and thus a periodic follow-up is mandatory. Cystoscopy in children is an invasive procedure that requires general anaesthesia, but it cannot be replaced by US and urine cytology. The present study has limitations, because it was retrospective and many abstracts were not available.
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![(a--c) Histological findings at both low (×100) and high (×400) power. Haematoxylin and eosin stain.](gr1){#f0005}

![An ultrasonogram showing the soft-tissue lesion in the left bladder wall.](gr2){#f0010}

![A cystoscopic view of a villous lesion above the left ureteric orifice.](gr3){#f0015}

![(a--c) Low- (×100) and high-power (×400) views showing the histopathology in sections with fragments of ulcerated bladder mucosa with intense mixed acute and chronic inflammatory infiltrate. There was one small fragment of papillary urothelium with enlarged crowded nuclei, consistent with low-grade papillary urothelial carcinoma. There was no stromal invasion. Haematoxylin and eosin stain.](gr4){#f0020}

###### 

A review of the 127 cases: All the studies were of level of evidence 5.

  Ref.                      Cases/sex                    Age (years)   Cell type                                  Treatment                  Outcome
  ------------------------- ---------------------------- ------------- ------------------------------------------ -------------------------- ------------------------------
  [@b0005]                  1/M                          4             High-grade (grade 3), muscle-invasive      TURBT, R after 3 months,   NR at 6 months
  Papillary UC, stage T2b   Partial cystectomy + chemo                                                                                       
  [@b0010]                  6/4M/2F                      6--17         Grade I TCC                                TURBT                      NR
  [@b0015]                  8/6M/2F                      \<18          Two G1Ta, 1 G1T1, 1 G2T1, and 5 G2Ta       TURBT                      NR 8--27 years
  [@b0020]                  1/M                          10            Grade I well-differentiated                TURBT                      Pending
  [@b0025]                  12/M                         \<21          Low-grade/low-stage                        TURBT                      1 patient had 1 R
  [@b0030]                  1/F                          9             Grade 1 TCC                                TURBT                      N/A
  [@b0035]                  5/M                          11--18        Low-grade                                  TURBT                      N/A
  [@b0040]                  7/M + F                      \<16          Low-grade                                  TURBT                      NR after 18 months
  [@b0045]                  1/M                          5             High-grade                                 Partial cystectomy         NR after 1 year
  [@b0050]                  1/F                          16            High-grade invasive TCC                    Radio- and chemotherapy    Died from metastatic disease
  [@b0060]                  1/F                          9             Low-grade                                  TURBT                      NR in 4 years
  [@b0065]                  2/M/F                        15/18         Superficial TCC                            TURBT                      N/A
  [@b0070]                  2/F                          8/9           Grade 1 stage pTa                          TURBT                      NR in 4 years
  [@b0075]                  1/F                          12            Superficial TCC                            TURBT                      N/A
  [@b0080]                  1/M                          10            Grade 2 TCC with lamina propria invasion   TURBT + Mitomycin          N/A
  [@b0085]                  1/F                          10            PUNLMP                                     TURBT                      NR in 9 months
  [@b0090]                  23/19M/4F                    4--20         2 papilloma, 10 PUNLMP, 8 low grade,       TURBT                      3 R in 13 years
  3 high grade                                                                                                                               
  [@b0095]                  1/M                          12            Ta grade II                                TURBT                      NR in 2 months
  [@b0100]                  1/M                          13            Low grade                                  TURBT                      N/A
  [@b0105]                  1/F                          10            Grade I papillary TCC                      TURBT                      R in 2 years
  [@b0110]                  1/M                          18            Grade 1 TCC                                TURBT                      NR in 2 years
  [@b0120]                  2/M                          \<20          Grade 1 and 2                              TURBT                      N/A
  [@b0125]                  1/M                          8             Grade I superficial (pTa)                  TURBT                      NR in 5 years
  [@b0130]                  2/M                          \<10          Low-grade                                  TURBT                      N/A
  [@b0135]                  6/4M/2F                      10--22        Low-grade and low-stage                    TURBT                      N/A
  [@b0140]                  1/M                          8             Papillary TCC with lymphangiectasia        TURBT                      N/A
  [@b0145]                  1/M                          11            Low-grade                                  TURBT                      N/A
  [@b0150]                  1/M                          13            Low-grade                                  TURBT                      N/A
  [@b0160]                  1/F                          8             Grade 1 TCC                                TURBT                      N/A
  [@b0165]                  7/M                          \<20          Low-grade                                  TURBT                      NR
  [@b0170]                  1/M                          14            Papillary noninvasive TCC                  TURBT                      N/A
  [@b0175]                  3/M                          \< 18         Low-grade                                  TURBT                      Two R
  [@b0185]                  1/M                          \<18          Grade II to III + submucosal invasion      TURBT                      NR in 30 months
  [@b0190]                  1/F                          10            Papillary carcinoma                        TURBT                      N/A
  [@b0200]                  1/M                          16            Grade I--II                                TURBT                      NR in 2 years
  [@b0205]                  2/M                          2--3          Papillary epithelial tumours               TURBT                      N/A
  [@b0225]                  1/M                          11            Papillary TCC                              TURBT                      N/A
  [@b0230]                  8/5M/3F                      10--20        Low-grade                                  TURBT                      NR in 7 years
  [@b0235]                  1/M                          \<18          Low-grade                                  TURBT                      N/A
  [@b0250]                  1/M                          10            Grade 1, noninvasive TCC                   TURBT                      NR in 2 years
  [@b0260]                  2/M                          \<18          Low-grade                                  TURBT                      1 R
  [@b0265]                  4/2F/2M                      2--18         Low-grade TCC                              TURBT                      NR at 3/6/4/1.5 years
  [@b0270]                  1/F                          16            Papillary TCC, grade I/Costello syndrome   TURBT                      NR in 2 years
  Present                   2/M                          5--12         Low-grade, 1 PUNLMP                        TURBT                      NR in 3 years

NR, no recurrence; R, recurrence; N/A, not available.

PUNLMP cases before 2004 were excluded.

No abstract available in [@b0195] (two cases), [@b0215] (one case) and [@b0220] (one case).

Some references were reviews or analysis without reporting the number of cases.
